SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom DuBois who wrote (977)7/15/1997 4:14:00 PM
From: JOHN W.   of 6136
 
I believe it was Rick who suggested a long time ago of a 49% deal/Chiron like deal/ etc. I just don't know. But what I am convinced of is something is in the works. Roche is tired of buying AGPH a piece of the time.

Look at the countries. Rick makes a good point on the demographics of who is pos and who can pay. However, These countries are developing very rapidly and the middle class is growing rapidly. HIV does not discriminate and attacks upper, middle, and lower classes.
Rick's demographic viewpoint is still valid and I have not given a single cent from non U.S. sales of nelf in my rev projections.

Regards, John.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News